Downey D - Search Results

1

Effect of cystic fibrosis exacerbations on neutrophil function.

Brockbank S, Downey D, Elborn JS, Ennis M. Brockbank S, et al. Among authors: downey d. Int Immunopharmacol. 2005 Mar;5(3):601-8. doi: 10.1016/j.intimp.2004.11.007. Int Immunopharmacol. 2005. PMID: 15683855

2

Nitric oxide, iNOS, and inflammation in cystic fibrosis.

Downey D, Elborn JS. Downey D, et al. J Pathol. 2000 Feb;190(2):115-6. doi: 10.1002/(SICI)1096-9896(200002)190:2<115::AID-PATH491>3.0.CO;2-V. J Pathol. 2000. PMID: 10657007

3

Safety of sputum induction.

Kelly MG, Downey DG, Ennis M, Elborn JS. Kelly MG, et al. Among authors: downey dg. Chest. 2000 Jul;118(1):276. doi: 10.1378/chest.118.1.276. Chest. 2000. PMID: 10893400 No abstract available.

4

Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients.

Moore JE, Shaw A, Millar BC, Martin SL, Murphy PG, Downey DG, Ennis M, Elborn JS. Moore JE, et al. Among authors: downey dg. Br J Biomed Sci. 2004;61(3):146-7. doi: 10.1080/09674845.2004.11732661. Br J Biomed Sci. 2004. PMID: 15462261 No abstract available.

5

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.

Martin SL, Downey D, Bilton D, Keogan MT, Edgar J, Elborn JS; Recombinant AAT CF Study Team. Martin SL, et al. Among authors: downey d. Pediatr Pulmonol. 2006 Feb;41(2):177-83. doi: 10.1002/ppul.20345. Pediatr Pulmonol. 2006. PMID: 16372352 Clinical Trial.

6

Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading?

Moore JE, Shaw A, Millar BC, Downey DG, Murphy PG, Elborn JS. Moore JE, et al. Among authors: downey dg. Br J Biomed Sci. 2005;62(4):175-8. doi: 10.1080/09674845.2005.11732707. Br J Biomed Sci. 2005. PMID: 16411377

7

The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis.

Downey DG, Martin SL, Dempster M, Moore JE, Keogan MT, Starcher B, Edgar J, Bilton D, Elborn JS. Downey DG, et al. Pediatr Pulmonol. 2007 Mar;42(3):216-20. doi: 10.1002/ppul.20553. Pediatr Pulmonol. 2007. PMID: 17238189

8

Glucocorticoids as an adjuvant treatment to intravenous antibiotics for cystic fibrosis pulmonary exacerbations: a UK Survey.

Hester KL, Powell T, Downey DG, Elborn JS, Jarad NA. Hester KL, et al. Among authors: downey dg. J Cyst Fibros. 2007 Jul;6(4):311-3. doi: 10.1016/j.jcf.2006.12.009. Epub 2007 Feb 8. J Cyst Fibros. 2007. PMID: 17291836 Free article.

9

The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation.

Downey DG, Brockbank S, Martin SL, Ennis M, Elborn JS. Downey DG, et al. Pediatr Pulmonol. 2007 Aug;42(8):729-35. doi: 10.1002/ppul.20646. Pediatr Pulmonol. 2007. PMID: 17588254 Free article.

10

Neutrophils in cystic fibrosis.

Downey DG, Bell SC, Elborn JS. Downey DG, et al. Thorax. 2009 Jan;64(1):81-8. doi: 10.1136/thx.2007.082388. Thorax. 2009. PMID: 19103874 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters